Alkermes Stock Price - ALKS

17.265
-0.505 (-2.84%)
Upgrade to Real-Time
Regular Market
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
Alkermes Plc ALKS NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
-0.505 -2.84% 17.265 17.11 17.73 17.67 17.77 10:35:59
Bid Price Ask Price Spread Spread % News
17.26 17.27 0.01 0.06% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
3,128 489,332 $ 17.37 $ 8,500,561 1,559,354 16.65 - 38.33
Last Trade Time Type Quantity Stock Price Currency
10:35:59 400 $ 17.265 USD

Alkermes Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 2.72B 157.52M $ -139.31M -0.89 -9.85 155.80M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% 9.00 1.30%

more financials information »

Alkermes News

Loading Messages....

Latest ALKS Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ALKS Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week19.1419.9716.6518.052,206,045-1.88-9.8%
1 Month19.1820.147316.6518.161,620,520-1.92-9.98%
3 Months21.7821.979916.6519.611,468,705-4.52-20.73%
6 Months22.0423.2216.6519.751,374,094-4.78-21.67%
1 Year32.3738.3316.6523.051,298,984-15.11-46.66%
3 Years54.5771.2216.6537.791,009,143-37.31-68.36%
5 Years70.8080.7116.6544.091,020,084-53.54-75.61%

Alkermes Description

Alkermes PLC is a fully integrated global biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in major therapeutic areas. The company utilizes several collaborative arrangements to develop and commercialize products and, in so doing, to access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies.


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.